P

Inventor

KORDASIEWICZ HOLLY

US21 patents
⚠️ This page may combine multiple inventors who share the name “KORDASIEWICZ HOLLY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

IONIS PHARMACEUTICALS INC

15 patents
US9683236B2Jun 20, 2017

Modulation of huntingtin expression

IONIS PHARMACEUTICALS INC5 citations84
US11136577B2Oct 5, 2021

Methods and compositions for inhibiting PMP22 expression

IONIS PHARMACEUTICALS INC4 citations83
US10407680B2Sep 10, 2019

Compounds and methods for reducing Tau expression

IONIS PHARMACEUTICALS INC12 citations83
US11421231B2Aug 23, 2022

Modulation of Huntington expression

IONIS PHARMACEUTICALS INC1 citations73
US10837016B2Nov 17, 2020

Modulation of huntingtin expression

IONIS PHARMACEUTICALS INC2 citations73
US10619158B2Apr 14, 2020

Modulation of huntingtin expression

IONIS PHARMACEUTICALS INC2 citations73
US10202603B2Feb 12, 2019

Modulation of huntingtin expression

IONIS PHARMACEUTICALS INC2 citations73
US11959080B2Apr 16, 2024

Methods and compositions for inhibiting PMP22 expression

IONIS PHARMACEUTICALS INC1 citations72
US10907160B2Feb 2, 2021

Methods for reducing LRRK2 expression

IONIS PHARMACEUTICALS INC4 citations70
US12350285B2Jul 8, 2025

Compounds and methods for reducing ATXN3 expression

IONIS PHARMACEUTICALS INC0 citations62
US12529055B2Jan 20, 2026

Methods and compositions for inhibiting PMP22 expression

IONIS PHARMACEUTICALS INC0 citations61
US12297431B2May 13, 2025

Modulation of huntingtin expression

IONIS PHARMACEUTICALS INC0 citations60
US11530411B2Dec 20, 2022

Methods for reducing LRRK2 expression

IONIS PHARMACEUTICALS INC0 citations60
US11230712B2Jan 25, 2022

Compounds and methods for reducing SNCA expression

IONIS PHARMACEUTICALS INC1 citations58
US11492615B2Nov 8, 2022

Antisense compounds and uses thereof

IONIS PHARMACEUTICALS INC0 citations47

BIOGEN MA INC

4 patents

ISIS PHARMACEUTICALS INC

1 patent

HUNG GENE

1 patent